Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart A Nicklin

Showing results (31-40 of 79) with videos related to

Pageof 8
Sort By:
Viruses|July 10, 2019
Human Adenovirus Serotype 5 Is Sensitive to IgM-Independent Neutralization In Vitro and In VivoAndor Doszpoly, Fernando de la Cuesta, Estrella Lopez-Gordo, et al.
Journal of Vascular Research|April 12, 2016
G-Protein-Coupled Receptor 35 Mediates Human Saphenous Vein Vascular Smooth Muscle Cell Migration and Endothelial Cell ProliferationJennifer E McCallum, Amanda E Mackenzie, Nina Divorty, et al.
Cardiovascular Research|March 11, 2020
RUNX1: an emerging therapeutic target for cardiovascular diseaseAlexandra Riddell, Martin McBride, Thomas Braun, et al.
The Journal of General Virology|May 19, 2016
Retargeting FX-binding-ablated HAdV-5 to vascular cells by inclusion of the RGD-4C peptide in hexon hypervariable region 7 and the HI loopStacy Robertson, Alan L Parker, Carolyn Clarke, et al.
Hypertension (Dallas, Tex. : 1979)|December 21, 2011
Angiotensin-(1-9) attenuates cardiac fibrosis in the stroke-prone spontaneously hypertensive rat via the angiotensin type 2 receptorMonica Flores-Munoz, Lorraine M Work, Kirsten Douglas, et al.
Cellular Signalling|September 6, 2020
Signalling pathways linking cysteine cathepsins to adverse cardiac remodellingDylan O'Toole, Ali Abdullah I Zaeri, Stuart A Nicklin, et al.
Human Gene Therapy|December 22, 2004
Adenoviral serotype 5 vectors pseudotyped with fibers from subgroup D show modified tropism in vitro and in vivoLaura Denby, Lorraine M Work, Delyth Graham, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 26, 2012
Biodistribution and inflammatory profiles of novel penton and hexon double-mutant serotype 5 adenovirusesAngela C Bradshaw, Lynda Coughlan, Ashley M Miller, et al.
Viruses|October 14, 2011
Tropism-modification strategies for targeted gene delivery using adenoviral vectorsLynda Coughlan, Raul Alba, Alan L Parker, et al.
Journal of Drug Targeting|April 26, 2005
Enhanced gene transfer activity of peptide-targeted gene-delivery vectorsAlan L Parker, Kerry D Fisher, David Oupicky, et al.
Pageof 8

Showing results (31-40 of 79) with videos related to

Sort By:
Pageof 8
Viruses|July 10, 2019
Human Adenovirus Serotype 5 Is Sensitive to IgM-Independent Neutralization In Vitro and In VivoAndor Doszpoly, Fernando de la Cuesta, Estrella Lopez-Gordo, et al.
Journal of Vascular Research|April 12, 2016
G-Protein-Coupled Receptor 35 Mediates Human Saphenous Vein Vascular Smooth Muscle Cell Migration and Endothelial Cell ProliferationJennifer E McCallum, Amanda E Mackenzie, Nina Divorty, et al.
Cardiovascular Research|March 11, 2020
RUNX1: an emerging therapeutic target for cardiovascular diseaseAlexandra Riddell, Martin McBride, Thomas Braun, et al.
The Journal of General Virology|May 19, 2016
Retargeting FX-binding-ablated HAdV-5 to vascular cells by inclusion of the RGD-4C peptide in hexon hypervariable region 7 and the HI loopStacy Robertson, Alan L Parker, Carolyn Clarke, et al.
Hypertension (Dallas, Tex. : 1979)|December 21, 2011
Angiotensin-(1-9) attenuates cardiac fibrosis in the stroke-prone spontaneously hypertensive rat via the angiotensin type 2 receptorMonica Flores-Munoz, Lorraine M Work, Kirsten Douglas, et al.
Cellular Signalling|September 6, 2020
Signalling pathways linking cysteine cathepsins to adverse cardiac remodellingDylan O'Toole, Ali Abdullah I Zaeri, Stuart A Nicklin, et al.
Human Gene Therapy|December 22, 2004
Adenoviral serotype 5 vectors pseudotyped with fibers from subgroup D show modified tropism in vitro and in vivoLaura Denby, Lorraine M Work, Delyth Graham, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 26, 2012
Biodistribution and inflammatory profiles of novel penton and hexon double-mutant serotype 5 adenovirusesAngela C Bradshaw, Lynda Coughlan, Ashley M Miller, et al.
Viruses|October 14, 2011
Tropism-modification strategies for targeted gene delivery using adenoviral vectorsLynda Coughlan, Raul Alba, Alan L Parker, et al.
Journal of Drug Targeting|April 26, 2005
Enhanced gene transfer activity of peptide-targeted gene-delivery vectorsAlan L Parker, Kerry D Fisher, David Oupicky, et al.
Pageof 8